Stephen Holgate (physician)

Sir Stephen Townley Holgate CBE FMedSci FRCP is the British Medical Research Council Clinical Professor of Immunopharmacology and Honorary Consultant Physician within Medicine at the University of Southampton.[2][3][4][5][6]

For the rugby league footballer, see Stephen Holgate.
Sir Stephen Holgate

CBE FMedSci FRCP
Born
Stephen Townley Holgate
Alma materImperial College London (MD)
Known forSynairgen
Awards
Scientific career
FieldsImmunopharmacology
Allergy
Asthma
Pollution[2]
InstitutionsUniversity of Southampton
ThesisBeta-Adrenergic Resistance - The development and Mechanisms in normal man (1978)
Websitewww.southampton.ac.uk/medicine/research/staff/sth.page

Education

Holgate was educated at Imperial College London where he was awarded a Doctor of Medicine (MD) degree in 1978.[7][8]

Career and research

Holgate's research interests include immunopharmacology, allergy, asthma and pollution.[2][9][8][10] In 2003 Holgate, Donna Davies and Ratko Djukanovic founded the University spin-off company Synairgen.[11][12][13]

Awards and honours

Holgate was appointed Commander of the Order of the British Empire (CBE) in the 2011 New Year Honours and was knighted in the 2020 Birthday Honours for services to medical research.[14]

Other awards include the King Faisal Prize, the Ellison–Cliffe Lecture and the J. Allyn Taylor International Prize in Medicine.

References
  1. Professor Stephen T. Holgate: Winner of the 1999 King Faisal International Prize (KFP Prize) for Medicine. Topic: Allergic Diseases. Co-winner: Professor Patrick G. Holt (in German)
  2. Stephen Holgate publications indexed by Google Scholar
  3. Stephen Holgate publications from Europe PubMed Central
  4. "Stephen Townley HOLGATE". London: Companies House.
  5. "Professor Stephen Holgate". southampton.ac.uk. University of Southampton. Retrieved 22 October 2017.
  6. "Professor Stephen T. Holgate - King Faisal International Prize". Kfip.org. Retrieved 22 October 2017.
  7. Holgate, Stephen Townley (1978). Beta-Adrenergic Resistance - The development and Mechanisms in normal man. london.ac.uk (MD thesis). University of London. OCLC 1006020949. EThOS uk.bl.ethos.459448.
  8. "Professor Stephen Holgate CBE - AAIR Charity". Aaircharity.org. Retrieved 22 October 2017.
  9. Holgate, Stephen (11 April 2012). "Tales from a career in medical research". theguardian.com. The Guardian. Retrieved 22 October 2017.
  10. "Prof. Stephen Holgate CBE". Synairgen.com. Archived from the original on 2017-10-23. Retrieved 22 October 2017.
  11. Holgate, Stephen; Agusti, Alvar; Strieter, Robert M.; Anderson, Gary P.; Fogel, Robert; Bel, Elisabeth; Martin, Thomas R.; Reiss, Theodore F. (2015). "Drug development for airway diseases: looking forward". Nature Reviews Drug Discovery. 14 (6): 367–368. doi:10.1038/nrd4645. ISSN 1474-1776. PMID 26000726.
  12. "Southampton respiratory drug discovery spin-out seeks partnership". sciencebusiness.net. Retrieved 2020-07-25.
  13. Neate, Rupert (2020-07-24). "'Major' breakthrough in Covid-19 drug makes UK professors millionaires". theguardian.com. London: The Guardian. ISSN 0261-3077. Retrieved 2020-07-25.
  14. "No. 63135". The London Gazette (Supplement). 10 October 2020. p. B2.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.